Thermostable FGF2 polypeptide, use thereof
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F23%3A00130823" target="_blank" >RIV/00216224:14310/23:00130823 - isvavai.cz</a>
Result on the web
<a href="https://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/3006388/summary.html" target="_blank" >https://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/3006388/summary.html</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Thermostable FGF2 polypeptide, use thereof
Original language description
The invention provides an isolated thermostable polypeptide possessing FGF2 activity and having at least 85% sequence identity to SEQ ID NO: 2 (FGF2 wt) or a functional fragment thereof, and comprising at least one amino acid substitution R31 L and the use thereof in the cell biology research, regenerative medicine and related medical applications or cosmetics. Further it discloses a culture medium comprising subjected FGF2 suitable for culturing a human pluripotent stem cells involving both human embryonic stem cells and induced pluripotent stem cells.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10600 - Biological sciences
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
CA3006388
Publisher
CA001 -
Publisher name
Canadian Intellectual Property Office (CIPO)
Place of publication
Gatineau, Québec
Publication country
CA - CANADA
Date of acceptance
May 9, 2023
Owner name
Masarykova univerzita; Enantis s.r.o.
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence